Vitrolife AB: Interim report Q2, 2025: Strong performance across Consumables

GOTHENBURG, Sweden, July 17, 2025 /PRNewswire/ --

Second quarter 

Sales of SEK 871 (941) million, a flat growth in local currencies and a 7% decrease in SEK, due to a significant currency impact of -8%. Organic growth in local currencies excluding discontinued business was 3%.

Sales per region, in local currencies was -3% in EMEA, +5% excluding discontinued business, +5% in Americas and 0% in APAC.

Sales per product group, in local currencies excluding discontinued business was +9% in Consumables, -6% in Technologies and +3% in Genetics.

Sales per product group, in local currencies was +5% in Consumables, -8% in Technologies and 0% in Genetics.

Gross margin decreased to 58.0% (59.9) also negatively impacted by currency.

Earnings before depreciation and amortisation (EBITDA) decreased to SEK 243 (327) million, resulting in an EBITDA margin of 27.8% (34.7), significantly impacted by negative currency effect.

Operating cash flow amounted to SEK 151 million (236).

Net income ...